MELISSA NIHISER: Open Payments
NPI 1033458831 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 25 payments from 12 companies in 2025. Trend: 2023 $1,248 · 2024 $1,256 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 4 | $158 |
| Edwards Lifesciences Corporation | 3 | $121 |
| Novo Nordisk Inc | 5 | $109 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| AngioDynamics, Inc. | 1 | $43 |
| Actelion Pharmaceuticals US, Inc. | 1 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| GENZYME CORPORATION | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: Barostim Neo System, SAPIEN 3 Ultra RESILIA, Wegovy, Kerendia, AURYON LASER SYSTEM 100-120 VAC, OPSUMIT, Cologuard Collection Kit, KEVZARA.
Industry payments across FL — which companies pay providers there.
